Furthermore, elevated blood levels of IL-6 have been observed in patients with NAFLD, and it is thought that IL-6 can induce insulin resistance and inflammation in the liver [22,23]. Here, IL6 is linked to metabolic dysfunction-associated steatotic liver disease.